Skip to main navigation Skip to search Skip to main content

ASPIRE us-2010: Linezolid's Impact Upon Immune Hyporesponsiveness After Influenza Infection

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/10 → 3/31/13

Funding

  • Pfizer Inc.: $100,000.00